Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
TransMedics Group, Inc. (TMDX) had Cost of Goods Sold of $72.77M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$173.93M |
|
$7.32M |
|
|
Cost of Goods Sold |
$72.77M |
$101.16M |
|
$160.64M |
|
$13.30M |
|
$-4.81M |
|
$8.48M |
|
$8.48M |
|
$7.32M |
|
$7.32M |
|
$7.32M |
|
$7.32M |
|
$13.30M |
|
$25.16M |
|
34.38M |
|
36.19M |
|
$0.21 |
|
$0.20 |
|
| Balance Sheet Financials | |
$619.28M |
|
$361.57M |
|
$815.54M |
|
$1.43B |
|
$91.92M |
|
$842.02M |
|
$848.89M |
|
$940.81M |
|
$494.01M |
|
$482.46M |
|
$494.01M |
|
34.55M |
|
| Cash Flow Statement Financials | |
$24.53M |
|
$-36.66M |
|
$3.76M |
|
$488.87M |
|
$480.18M |
|
$-8.69M |
|
$9.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.74 |
|
-- |
|
-- |
|
0.63 |
|
1.73 |
|
58.16% |
|
7.64% |
|
7.64% |
|
-- |
|
4.88% |
|
4.21% |
|
$-12.12M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
1.46 |
|
1.92 |
|
46.95 |
|
1.48% |
|
1.52% |
|
0.51% |
|
0.55% |
|
$14.30 |
|
$-0.34 |
|
$0.68 |
|